Chemical Compound

2-PIPERIDINECARBOXYLIC ACID, 1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-, (2E,4R,6E,8R)-

CAS Registry Number 147438-27-5
2-PIPERIDINECARBOXYLIC ACID, 1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-, (2E,4R,6E,8R)- 结构式
Primary record

2-PIPERIDINECARBOXYLIC ACID, 1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-, (2E,4R,6E,8R)-

库存
7,485 克
纯度
99.5 %
CAS
147438-27-5

化合物标识与属性

CAS
147438-27-5
PubChem CID
71772274
SMILES
C[C@@H]1CC[C@H](O[C@]1(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)O)/C)O)OC)/C)OC
Canonical SMILES
CO[C@@H](C[C@@H]1CC[C@@H](C)[C@](O)(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O1)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]1CC[C@@H](O)[C@H](OC)C1

名称与同义词

  • Seco Rapamycin
  • Secorapamycin A
  • Sirolimus open ring
  • Rapamycin Impurity 1
  • Rapamycin Impurity 24
  • ZVF9AF2S67
  • RefChem:1098399
  • UNII-ZVF9AF2S67
  • 147438-27-5
  • orb1691667
  • SCHEMBL7709877
  • Secorapamycin A(Seco Rapamycin)
  • AKOS040756844
  • ZINC263590167
  • HY-19555
  • CS-0015640
  • (2S)-1-[2-[(2R,3R,6S)-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaenyl]-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylic acid
  • (2E,4R,6E,8R)-1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-2-PIPERIDINECARBOXYLIC ACID
  • (S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid
  • 2-PIPERIDINECARBOXYLIC ACID, 1-(2-OXO-2-((2R,3R,6S)-TETRAHYDRO-2-HYDROXY-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-HYDROXY-22-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-2,13-DIMETHOXY-3,9,11,15,17,21-HEXAMETHYL-12,18-DIOXO-3,5,7,15,19-DOCOSAPENTAEN-1-YL)-3-METHYL-2H-PYRAN-2-YL)ACETYL)-, (2E,4R,6E,8R)-